| Document Date: 2015-05-08 05:38:40
Open Document File Size: 487,26 KBShare Result on Facebook
City Helsinki / / Company Qiagen / Metsola Ventures / Synoste Oy / High-Tech Gründerfonds Management GmbH / Bayer / Deutsche Post / KfW Banking Group / Lifeline Ventures / Finnvera Finnvera Venture Capital / Deutsche Telekom / Daimler / CE / ALTANA / Mectalent Oy / Beteiligungs GmbH & Co. KG / BASF / Kalle Åström Finnvera plc Venture Capital / / Continent Europe / / Country Finland / / Currency EUR / / / Event M&A / Funding / / Facility Aalto University / ORTON Orthopaedic Hospital / / / IndustryTerm high-tech / craniomaxilofacial applications / product technology / component manufacturing / medical technology / / Organization Federal Ministry of Economics and Technology / Aalto University / Espoo and ORTON Orthopaedic Hospital / Export Credit Agency / / Person Harri Hallila / Robert Bosch / Kay G. Balster / Petri Pöyhönen / Michael Piccirillo / Timo Ahopelto Kalevankatu / Kay Balster Schlegelstraße / / / Position responsible Manager / CEO and co-founder / Olli Karhi Chairman / Private / Director of Business Development / entrepreneur / / Technology product technology / / URL http /
SocialTag |
Synoste Oy raises € 2.2 M in the first closing of A-round financing to acquire CE-approval for a next generation implant for correcting skeletal deformities Synoste Oy, a Finnish medical device company is developing a